SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-034551
Filing Date
2023-03-20
Accepted
2023-03-20 17:26:34
Documents
13
Period of Report
2023-03-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310042d1_8k.htm   iXBRL 8-K 34620
2 EXHIBIT 99.1 tm2310042d1_ex99-1.htm EX-99.1 10162
  Complete submission text file 0001104659-23-034551.txt   227482

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA azyo-20230320.xsd EX-101.SCH 3025
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE azyo-20230320_lab.xml EX-101.LAB 34477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azyo-20230320_pre.xml EX-101.PRE 22590
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2310042d1_8k_htm.xml XML 3750
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 23747213
SIC: 2836 Biological Products, (No Diagnostic Substances)